SCHEMBL1678611

SCHEMBL1678611

C=CCC(C(=O)O)c1cnc(-c2ccc(O)cc2)nc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.53
MEN1 O00255 3/20 0.44
RAB9A P51151 3/20 0.44
KMT2A Q03164 3/20 0.44
NPC1 O15118 2/20 0.44
NR1H2 P55055 1/20 0.35
NR1H3 Q13133 1/20 0.35
MAPK1 P28482 1/20 0.34
PIK3CA P42336 1/20 0.34
MAPT P10636 2/20 0.33
USP2 O75604 1/20 0.33
TP53 P04637 1/20 0.33
PKM P14618 1/20 0.33
NFKB1 P19838 1/20 0.33
NFKB2 Q00653 1/20 0.33
RELA Q04206 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
ALDH5A1 P51649 1/20 0.33
ABAT P80404 1/20 0.33
LMNA P02545 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11077670 0.80 CYP2C19 (0.73) CYP2C19KMT2AMAPTALDH5A1ABAT
SCHEMBL1679289 0.76 CYP2C19 (0.43) CYP2C19RAB9ANPC1MAPTNFKB1
SCHEMBL9785525 0.72 CYP2C19 (0.53) CYP2C19NR1H2NR1H3P4HTMFFAR2
SCHEMBL9785672 0.72 CYP2C19 (0.53) CYP2C19NR1H2NR1H3P4HTMFFAR2
SCHEMBL1679476 0.72 CYP2C19 (0.59) CYP2C19MEN1KMT2AMAPTLMNA
SCHEMBL1679513 0.72 CYP2C19 (0.49) CYP2C19HSD17B10ESR1ESR2
SCHEMBL5156636 0.71 CYP2C19 (0.80) CYP2C19LMNA
SCHEMBL1458057 0.70 CYP2C19 (1.00) CYP2C19MAPK1MAPTSMN1; SMN2LMNA
SCHEMBL666893 0.70 CYP2C19 (1.00) CYP2C19MAPK1MAPTSMN1; SMN2LMNA
SCHEMBL1458050 0.70 CYP2C19 (1.00) CYP2C19MAPK1MAPTSMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7923573-B2 Benzene compound having 2 or more substituents DAIICHI SANKYO COMPANY, LIMITED (JP) 2011-04-12 US disclosed
US-20080004301-A1 Benzene Compound Having 2 or More Substituents DAIICHI SANKYO COMPANY, LIMITED (JP) 2008-01-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080004301-A1 Benzene Compound Having 2 or More Substituents NR1H2, NR1H3, NCOR2 CYP2C19 238/4885MEN1 4333/4885RAB9A 956/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.